NCT00019630 2024-03-04Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed
NCT00020267 2024-03-04Vaccine Therapy in Treating Patients With Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT03525392 2023-12-12Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.IpsenPhase 1 Terminated14 enrolled 20 charts
NCT00423254 2010-08-03Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.Mannkind CorporationPhase 1 Completed12 enrolled